XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities
6 Months Ended
Jun. 30, 2023
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities  
Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities

5.

Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities

Our marketable investment securities, restricted cash and cash equivalents, and other investment securities consisted of the following:

As of

June 30,

December 31,

2023

    

2022

 

(In thousands)

Marketable investment securities:

Current marketable investment securities:

Strategic - available-for-sale

$

144

$

144

Strategic - trading/equity

83

655

Other

747,522

835,184

Total current marketable investment securities

747,749

835,983

Restricted marketable investment securities (1)

41,098

41,689

Total marketable investment securities

788,847

877,672

Restricted cash and cash equivalents (1)

65,982

62,925

Other investment securities:

Other investment securities

177,506

168,200

Total other investment securities

177,506

168,200

Total marketable investment securities, restricted cash and cash equivalents, and other investment securities

$

1,032,335

$

1,108,797

(1)Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets.

Marketable Investment Securities

Our marketable investment securities portfolio consists of and may consist of debt and equity instruments. All equity securities are carried at fair value, with changes in fair value recognized in “Other, net” within “Other Income (Expense)” on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). All debt securities are classified as available-for-sale and are recorded at fair value. We report the temporary unrealized gains and losses related to changes in market conditions of marketable debt securities as a separate component of “Accumulated other comprehensive income (loss)” within “Stockholders’ Equity (Deficit),” net of related deferred income tax on our Condensed Consolidated Balance Sheets. The corresponding changes in the fair value of marketable debt securities, which are determined to be company specific credit losses are recorded in “Other, net” within “Other Income (Expense)” on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Current Marketable Investment Securities Strategic

Our current strategic marketable investment securities portfolio includes and may include strategic and financial debt and/or equity investments in private and public companies that are highly speculative and have experienced and continue to experience volatility. As of June 30, 2023, this portfolio consisted of securities of a small number of issuers, and as a result the value of that portfolio depends, among other things, on the performance of those issuers. The fair value of certain of the debt and equity securities in this portfolio can be adversely impacted by, among other things, the issuers’ respective performance and ability to obtain any necessary additional financing on acceptable terms, or at all.

Current Marketable Investment Securities - Other

Our current other marketable investment securities portfolio includes investments in various debt instruments including, among others, commercial paper, corporate securities and United States treasury and/or agency securities.

Commercial paper consists mainly of unsecured short-term, promissory notes issued primarily by corporations with maturities ranging up to 365 days. Corporate securities consist of debt instruments issued by corporations with various maturities normally less than 18 months. U.S. Treasury and agency securities consist of debt instruments issued by the federal government and other government agencies.

Restricted Cash, Cash Equivalents and Marketable Investment Securities

As of June 30, 2023 and December 31, 2022, our restricted marketable investment securities, together with our restricted cash and cash equivalents, included amounts required as collateral for our letters of credit and trusts.

Other Investment Securities

We have strategic investments in certain debt and/or equity securities that are included in noncurrent “Other investment securities” on our Condensed Consolidated Balance Sheets. Our debt securities are classified as available-for-sale and are recorded at fair value, and our equity securities are accounted for using the equity method of accounting or recorded at fair value. Certain of our equity method investments are detailed below.

NagraStar L.L.C. We own a 50% interest in NagraStar L.L.C. (“NagraStar”), a joint venture that is our primary provider of encryption and related security systems intended to assure that only authorized customers have access to our programming.

Invidi Technologies Corporation. In November 2016, we, AT&T Inc., and Cavendish Square Holding B.V., an affiliate of WPP plc, entered into a series of agreements to acquire Invidi Technologies Corporation (“Invidi”), an entity that provides proprietary software for the addressable advertising market.

TerreStar Solutions, Inc.  In March 2019, we closed a transaction with TerreStar Solutions, Inc. (“TSI”) to acquire additional equity securities of TSI, an entity that holds certain 2 GHz wireless spectrum licenses in Canada, in exchange for certain Canadian assets, including, among other things, a portion of the satellite capacity on our T1 satellite, which we had acquired from TerreStar Networks, Inc. in 2012. 

Our ability to realize value from our strategic investments in securities that are not publicly traded depends on, among other things, the success of the issuers’ businesses and their ability to obtain sufficient capital, on acceptable terms or at all, and to execute their business plans. Because private markets are not as liquid as public markets, there is also increased risk that we will not be able to sell these investments, or that when we desire to sell them we will not be able to obtain fair value for them.

Fair Value Measurements

Our investments measured at fair value on a recurring basis were as follows:

As of

June 30, 2023

December 31, 2022

    

Total  

    

Level 1

    

Level 2

    

Level 3

    

Total  

    

Level 1

    

Level 2

    

Level 3

 

(In thousands)

Cash equivalents (including restricted)

$

815,719

$

191,145

$

624,574

$

$

1,620,458

$

174,050

$

1,446,408

$

 

Debt securities (including restricted):

U.S. Treasury and agency securities

$

2,621

$

2,621

$

$

$

22,824

$

22,824

$

$

Commercial paper

756,225

756,225

696,324

696,324

Corporate securities

27,428

27,428

156,380

156,380

Other

2,490

2,346

144

1,489

1,345

144

Equity securities

83

83

655

655

Total

$

788,847

$

2,704

$

785,999

$

144

$

877,672

$

23,479

$

854,049

$

144

As of June 30, 2023, restricted and non-restricted marketable investment securities included debt securities of $786 million with contractual maturities within one year and $3 million with contractual maturities extending longer than one year through and including five years. Actual maturities may differ from contractual maturities as a result of our ability to sell these securities prior to maturity.

Derivative Instruments

We have the option to purchase certain of T-Mobile’s 800 MHz spectrum licenses from T-Mobile at a fixed price.  This instrument meets the definition of a derivative and is valued based upon, among other things, our estimate of the underlying asset price, the expected term, volatility, the risk free rate of return and the probability of us exercising the option. The instrument acquisition date fair value was $713 million. The derivative is remeasured quarterly. As of June 30, 2023 and December 31, 2022, the derivative’s fair value was $1.656 billion and $1.693 billion, respectively, and is included in “Other noncurrent assets, net” on our Condensed Consolidated Balance Sheets. All changes in the derivative’s fair value are recorded in “Other, net” on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) until the option is either exercised or expires. See the table below. If we elect to exercise the option and purchase these licenses, we will record the licenses at fair value at that date in “FCC authorizations” on our Condensed Consolidated Balance Sheets. If we elect to not exercise the option or it expires, we will expense the derivative’s fair value at that date on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and are potentially subject to pay T-Mobile a fee of approximately $72 million per the Spectrum Purchase Agreement under certain circumstances. See our Annual Report on Form 10-K for the year ended December 31, 2021 for further information on the Spectrum Purchase Agreement.

On June 30, 2023, the Department of Justice provided notice to the United States District Court for the District of Columbia that, pursuant to its discretion under the Final Judgment, it granted a 60-day extension of the deadline for T-Mobile to divest the 800 MHz spectrum licenses, which expires on August 30, 2023. We are currently in negotiations with T-Mobile.

We account for our option to purchase certain T-Mobile’s 800 MHz spectrum licenses under the Spectrum Purchase Agreement as a Level 3 instrument within the fair value hierarchy.

Gains and Losses on Sales and Changes in Carrying Amounts of Investments and Other

“Other, net” within “Other Income (Expense)” included on our Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) is as follows:

For the Three Months Ended 

For the Six Months Ended 

June 30,

June 30,

Other, net:

    

2023

    

2022

    

2023

    

2022

    

 

(In thousands)

Marketable and non-marketable investment securities - realized and unrealized gains (losses)

$

1,720

$

37

$

1,412

$

(411)

Derivative instruments - net realized and/or unrealized gains (losses)

(8,013)

15,000

(36,974)

58,000

Gains (losses) related to early redemption of debt (1)

68,037

(1,143)

68,086

(1,149)

Equity in earnings (losses) of affiliates

(929)

857

(2,380)

1,257

Other

477

(976)

627

(1,374)

Total

$

61,292

$

13,775

$

30,771

$

56,323

(1)This change primarily resulted from repurchases of our Convertible Notes during the three months ended June 30, 2023.